Duopharma Biotech Berhad (KLSE: DPHARMA)
Malaysia
· Delayed Price · Currency is MYR 1.250
+0.040 (3.31%)
At close: Jan 31, 2025
Duopharma Biotech Berhad Revenue
Duopharma Biotech Berhad had revenue of 208.73M MYR in the quarter ending September 30, 2024, with 23.34% growth. This brings the company's revenue in the last twelve months to 787.53M, up 14.27% year-over-year. In the year 2023, Duopharma Biotech Berhad had annual revenue of 704.73M with 1.15% growth.
Revenue (ttm)
787.53M
Revenue Growth
+14.27%
P/S Ratio
1.53
Revenue / Employee
477.29K
Employees
1,650
Market Cap
1.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 704.73M | 8.01M | 1.15% |
| Dec 31, 2022 | 696.72M | 57.54M | 9.00% |
| Dec 31, 2021 | 639.18M | 69.27M | 12.16% |
| Dec 31, 2020 | 569.90M | -6.56M | -1.14% |
| Dec 31, 2019 | 576.46M | 77.74M | 15.59% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Malayan Banking Berhad | 27.35B |
| CIMB Group Holdings Berhad | 20.94B |
| Public Bank Berhad | 13.52B |
| Tenaga Nasional Berhad | 65.49B |
| IHH Healthcare Berhad | 22.98B |
| Celcomdigi Berhad | 12.80B |
| Hong Leong Bank Berhad | 6.03B |
| Press Metal Aluminium Holdings Berhad | 14.88B |